How do I buy Kodiak Sciences Inc (KOD) stock?

Buying Kodiak Sciences Inc (KOD) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "KOD", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy KOD by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if KOD is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Kodiak Sciences Inc (KOD) Stock

Q: What is the minimum investment for KOD on Gotrade?

On Gotrade , you don't have to buy a full lot. With fractional shares, you can start investing in Kodiak Sciences Inc from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · KOD

Trade KOD

Key stats

Market cap: $5.10B
Price / Earnings ratio: -21.1x
EPS (TTM): -$4.19
Volume: Loading
52-week high: $104.00
52-week low: $12.64

Source: third-party data provider, as of October 16, 2026

Compare with KOD

Technical indicators

RSI 14: 63.36
MACD 12/26/9: 13.18
EMA 9 of MACD: 13.75
MACD histogram: -0.57
SMA 50: $52.80; Price above SMA 50
EMA 50: $60.62; Price above EMA 50
SMA 200: $38.54; Price above SMA 200
EMA 200: $40.46; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of October 15, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 5 analyst ratings

Strong Sell0

Sell0

Hold1

Buy4

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

No data available

Debt & Balance Sheet

No data available

Revenue to Profit

No data available

Earnings

EPS forecast

Actual EPS

$-1.04

Q4FY25

$-0.77

Q1FY26

$-0.95

Q2FY26

The market is expecting earnings per share of -$0.95 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Kodiak Sciences Inc

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

SectorHealthcare

IndustryBiotechnology

Employees141

CEODr. Victor Perlroth M.D.

IPO DateOct 4, 2018

HeadquartersPalo Alto, CA

Key Executives

Name	Title	Year Born
Dr. Victor Perlroth M.D.	Co-Founder, Chairman, CEO & President	1974
Mr. John A. Borgeson CPA, M.B.A.	Executive VP, CFO & Secretary	1963
Mr. Wayne To M.Phil.	Chief Technology Officer	—
Dr. Dolly S. Chang M.D., M.P.H., Ph.D.	Chief Scientific Officer	—
Dr. Hong Liang Ph.D.	Senior Vice President of Development	1972
Dr. Stephen Raillard Ph.D.	Senior Vice President of Chemical Development & Manufacturing	—
Ms. Almas Qudrat M.Sc.	Chief Quality Officer	—
Dr. J. Pablo Velazquez-Martin M.D.	Chief Medical Officer	—
Dr. Laurent Ducay Ph.D.	Senior VP of Biologics Development & Manufacturing	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021										+4.8	-27.1	-3.6
2022	-34.4	-86.1	-12.7	-23.6	+12.4	+1.5	+28.4	+4.8	-26.9	-5.5	+4.1	-1.8
2023	+4.0	-21.0	-3.1	-19.5	+30.6	+8.7	-57.0	-26.7	-25.0	-13.7	+57.1	+18.3
2024	+26.1	+36.9	-12.5	-27.9	-9.9	-27.5	+22.8	-13.1	+7.9	+46.2	+73.7	+33.9
2025	-25.8	-29.4	-27.9	+70.3	-24.3	+3.6	+75.0	+35.9	+89.9	+15.0	+23.8	+27.4
2026	-12.5	+11.2	+39.3	+1.6	-16.5	+5.6	+11.7	-6.2	+155.8	-10.5

Stocks in the same sector

Vertex Pharmaceuticals

ABEO

Abeona Therapeutics Inc.

FAQ

Buying Kodiak Sciences Inc (KOD) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and complete KYC.
Make a deposit.
Search for the code "KOD", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy KOD by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Kodiak Sciences Inc from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Kodiak Sciences Inc (KOD) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track KOD's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB, or 8:30 PM to 3:00 AM WIB during Daylight Saving Time. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.

Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trading Lebih Cepat. Lebih Mudah. Lebih Cerdas.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Kodiak Sciences Inc (KOD) Stock

Key stats

Compare with KOD

Recent news

Kodiak Sciences' Two Wet AMD Treatments Match Aflibercept in Phase III Study

Kodiak Sciences' Two Wet AMD Treatments Match Aflibercept in Phase III Study

OCUL Stock On Track For Worst Week In 2.5 Years As Rivals Raise The Bar In Wet AMD

OCUL Stock On Track For Worst Week In 2.5 Years As Rivals Raise The Bar In Wet AMD

A $32 Biotech Became a $90 Biotech Overnight. Is It Too Late to Buy Kodiak?

A $32 Biotech Became a $90 Biotech Overnight. Is It Too Late to Buy Kodiak?

KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears

KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Kodiak Sciences' Two Wet AMD Treatments Match Aflibercept in Phase III Study

Kodiak Sciences' Two Wet AMD Treatments Match Aflibercept in Phase III Study

OCUL Stock On Track For Worst Week In 2.5 Years As Rivals Raise The Bar In Wet AMD

OCUL Stock On Track For Worst Week In 2.5 Years As Rivals Raise The Bar In Wet AMD

A $32 Biotech Became a $90 Biotech Overnight. Is It Too Late to Buy Kodiak?

A $32 Biotech Became a $90 Biotech Overnight. Is It Too Late to Buy Kodiak?

KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears

KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears

Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs?

Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs?

Dow, S&P 500, Nasdaq Futures Fall Amid Rising Bond Yields, AI Concerns: KOD, SMMT, CLF, VKTX Stocks In Focus

Dow, S&P 500, Nasdaq Futures Fall Amid Rising Bond Yields, AI Concerns: KOD, SMMT, CLF, VKTX Stocks In Focus

Why Kodiak Sciences Skyrocketed Today

Why Kodiak Sciences Skyrocketed Today

KOD Stock Cracks September’s Top 5 Biotech Gainers On Eye Drug Win — But ‘Pharma Bro’ Shkreli Says It ‘Still Sucks’

KOD Stock Cracks September’s Top 5 Biotech Gainers On Eye Drug Win — But ‘Pharma Bro’ Shkreli Says It ‘Still Sucks’

Kodiak Sciences soars as Zenkuda, tabirafusp-ted hit primary endpoints in phase III wet AMD trial

Kodiak Sciences soars as Zenkuda, tabirafusp-ted hit primary endpoints in phase III wet AMD trial

OCUL Stock Suffers Sharpest Drop Since February As KOD And FDMT Post Updates On Their Wet AMD Drugs

OCUL Stock Suffers Sharpest Drop Since February As KOD And FDMT Post Updates On Their Wet AMD Drugs

About Kodiak Sciences Inc

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trading Lebih Cepat. Lebih Mudah. Lebih Cerdas.

#ReadyGoTrade